US 8013005
Dual-acting antihypertensive agents
granted A61KA61K31/415A61K31/4164
Quick answer
US patent 8013005 (Dual-acting antihypertensive agents) held by Theravance, Inc. expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/415, A61K31/4164, A61K31/417, A61K31/4188